Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

entities : Blueprint medicines corporation    crawled time : 15:01    save search

Blueprint Medicines Submits Supplemental New Drug Application to FDA for AYVAKIT™ (avapritinib) for the Treatment of Advanced Systemic Mastocytosis
Published: 2020-12-17 (Crawled : 15:01) - biospace.com/
BPMC | $88.395 2.68% 2.61% 730K twitter stocktwits trandingview |
Health Technology
| | O: 0.01% H: 0.78% C: 0.66%

drug fda treatment new drug application
Gainers vs Losers
56% 44%

Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M twitter stocktwits trandingview |
Health Technology

SINT | $0.0365 59.39% 37.26% 470M twitter stocktwits trandingview |
Health Technology

WISA 4 | $9.19 50.66% 33.7% 65M twitter stocktwits trandingview |
Electronic Technology

EDBL | News | $6.73 47.91% 32.39% 13M twitter stocktwits trandingview |

GCTK | $0.715 36.27% 26.62% 640K twitter stocktwits trandingview |
Manufacturing

TCON | $2.33 36.26% 26.61% 2M twitter stocktwits trandingview |
Health Technology

TIRX | $0.48 6.43% 24.58% 4.8M twitter stocktwits trandingview |

KZIA | $0.38 30.58% 23.42% 300K twitter stocktwits trandingview |
Health Technology

VNDA | News | $5.23 29.14% 22.56% 24M twitter stocktwits trandingview |
Health Technology

ATNF | $1.91 29.05% 22.51% 310K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.